Question-and-Answer SessionSean McCarthyChairman & CEO Yes. Thanks, Ross, and thanks for having us at the conference today. Real pleasure to be here. So CytomX is an oncology-focused biologics company, developing a platform technology and a pipeline around that platform called the Probody therapeutic platform. And this is a unique antibody masking strategy that we pioneered. In fact, I refer to CytomX as the original masking company. We got this whole field going really going back as long as 15 years. And t ...